Virus

Летећи Полип wrote:Dakle, onaj jeftini lik što može svako da ga pravi najednom ne radi. A onaj skupi radi. Ko bi rekao...

Ferenc Puskás wrote:

Летећи Полип wrote:Dakle, onaj jeftini lik što može svako da ga pravi najednom ne radi. A onaj skupi radi. Ko bi rekao...

 Kako je pogino Krcun?

Srdja Janković je, danas, na KZN rekao: ako osoba koja ima druge bolesti premine od tih bolesti a pozitivna je na Covid 19-onda ne ulazi u statistiku preminulih od virusa.

A, zato mi imamo najnižu stopu smrtnosti.

— Kuke i motike (@UsraneMotke) April 22, 2020

Prema uredbi Vlade Severne Makedonije, zaštitna oprema na licu mora obavezno da se nosi u svim zatvorenim javnim prostrima gde ima više ljudi, kao što su marketi, prodavnice, banke, pošte, državne i zdravstvene ustanove, javni prevoz.

Na otovorenom prostoru maske moraju obavezno da se nose na pijacama i na mestima gde ne postoji mogućnost da se održava fizička distanca od dva metra.

Građani neće morati da nose zaštitnu opremu kada su u svojim dvorištima, kada voze bicikl, bave se se individualnim sportom ili se voze automobilom sa bliskima.

Marius Lăcătuș wrote:izvoli

https://twitter.com/mali_gad

zaključan je ali nije problem da te pusti

NEWS RELEASE
COVID-19 SEROPREVALENCE: FIRST ESTIMATE OF THE PREVALENCE OF COV-2 IGG ANTIBODIES IN THE POPULATION OF GENEVA

Wednesday 22nd April 2020

- First estimation of the prevalence of anti-SARS-CoV-2 IgG antibodies in the Geneva population - First validation of an automated serological testing platform against the new coronavirus

The University Hospitals of Geneva (HUG), more specifically the Population Epidemiology Unit of the Service de médecine de première recours, the Centre for Emerging Viral Diseases and the Service de Médecine de Laboratoire, conducted a study to estimate the prevalence of anti-SARS-CoV-2 IgG antibodies in a representative sample of the Geneva population. The minimum global seroprevalence of 5.5% suggests that as of 17 April 2020, approximately 27'000 people have been exposed to SARS-CoV-2 in the canton of Geneva.

Prior to this, the HUG conducted a study to validate the performance of a high-throughput serological testing platform that measures type G immunoglobulins (IgG) directed against SARS-CoV 2. This is the only high-throughput facility (200 tests/hour) currently available. The results of the study indicate that this test reliably confirms exposure to CoV-SARS-2 20 days after the onset of symptoms. The platform is being used for the population-based study mentioned above.

Seroprevalence surveys based on the detection of specific immunoglobulin type G (IgG) are of utmost importance to know the proportion of the population that has ever been exposed to coronavirus. The presence of these immunoglobulins (antibodies) in the blood confirms that a person has been exposed to the virus. However, the presence of immunoglobulins (antibodies) in the blood does not indicate full or partial immunity to the virus. Indeed, at the present state of knowledge, we know neither the level of protection that this immunity confers against a new infection nor its possible duration. For this reason, the test is not yet available to the general population.

In order to evaluate the seroprevalence of anti-SARS-CoV-2 antibodies in the canton of Geneva, the HUG launched a survey among a representative sample of the population. People who had already participated in the Bus Santé study (annual health survey of the canton's population) were randomly selected and invited with their families to take a blood sample and fill in a questionnaire. The study began on 6 April 2020 and runs until the end of May.

Preliminary results are based on the first 760 participants, i.e. 343 (54% women, 46% men, 87% adults and 13% minors) between 6 and 10 April and 417 participants (53% women, 47% men, 87% adults and 13% minors) for the week of 14 to 17 April 2020.

These first data show an estimated seroprevalence in the population of 3.5% (possible variability from 1.6% to 5.4%) for the first week and 5.5% (possible variability from 3.3% to 7.7%) for the second week. This sample, and the time period studied, are too small to infer with certainty the percentage weekly increase, but a significant increase was observed between the two weeks.

The overall seroprevalence of 5.5% suggests that almost 27,000 people were exposed to SARS-CoV-2 in the canton of Geneva. This is a minimal estimate, probably linked to multiple uncertainties, including the time needed to develop immunity and the dynamics of the epidemic. It is expected that this seroprevalence in the population will increase in the coming weeks due to the recent increase in the number of cases in the canton.

Interpretation of these seroprevalence estimates must be made with great caution. The still limited number of participants, the short duration of follow-up, and the influence of the performance of serological tests must be taken into account. Monitoring changes in seroprevalence over time is particularly important for anticipating and planning the public health response.

Talason wrote:dobar je rujević, pravi levičar

erős paprika wrote:ne ulazeci u raspravu oko rujewitcha samo da primetim da bi bilo moguce da je svedcka u pravu te da je njen model potpuno neprimenljiv na dotrajalo srbijansko zdravstvo.